Drawing for ARMOLIPID

USPTO serial 79024800

ARMOLIPID

Reviewed by CopyMark Law Group

Reg. 3286569Status 404
Filing date
Status date
Registration date
Aug 28, 2007
Examiner
BROWNE, DAYNA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARMOLIPID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS IN THE CARDIOVASCULAR FIELD; DIETETIC SUBSTANCES ADAPTED FOR MEDICAL USE, FOOD FOR BABIES; MEDICAL PLASTERS; MATERIAL FOR STOPPING TEETH AND DENTAL WAX; PREPARATIONS FOR DESTROYING VERMIN; FUNGICIDES, HERBICIDESSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 5, 2025DETHDEATH OF INTERNATIONAL REGISTRATION
Dec 2, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 2, 2015GPNXNOTIFICATION PROCESSED BY IB
Oct 2, 2015OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 11, 2015RFNPREFUSAL PROCESSED BY IB
Jun 19, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB
May 5, 2015XXSSGENERIC MADRID TRANSACTION SENT TO IB
May 5, 2015XXCRGENERIC MADRID TRANSACTION CREATED
May 1, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED
Jan 2, 2015RNWLINTERNATIONAL REGISTRATION RENEWED
Dec 4, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 4, 2014C71TCANCELLED SECTION 71
Sep 19, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Dec 14, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2007FIMPFINAL DISPOSITION PROCESSED
Dec 5, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 28, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 12, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 23, 2007NPUBNOTICE OF PUBLICATION
Apr 7, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 7, 2007ALIEASSIGNED TO LIE
Mar 15, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 5, 2006RFNTREFUSAL PROCESSED BY IB
Sep 14, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 14, 2006RFRRREFUSAL PROCESSED BY MPU
Sep 13, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 12, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2006DOCKASSIGNED TO EXAMINER
Jul 14, 2006NWAPNEW APPLICATION ENTERED
Jul 13, 2006SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance